| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.12.25 | TSP Advanced Technologies loss narrows amid cost management | 1 | Alliance News | ||
| 30.12.25 | TSP Advanced Technologies reports £335k loss in H1 2025 | 2 | Investing.com | ||
| 30.12.25 | TSP Advanced Technologies reduziert Halbjahresverlust auf 335.000 £ | 3 | Investing.com Deutsch | ||
| 30.12.25 | TSP Advanced Tech. - Half-year Report | - | RNS | ||
| 10.12.25 | TSP Advanced Tech. - Result of 2025 AGM | - | RNS | ||
| 17.11.25 | TSP Advanced Technologies beruft Hauptversammlung für den 10. Dezember 2025 ein | - | Investing.com Deutsch | ||
| 17.11.25 | TSP Advanced Technologies to hold 2025 AGM on December 10 | - | Investing.com | ||
| TSP ADVANCED TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 17.11.25 | TSP Advanced Tech. - Notice of AGM | - | RNS | ||
| 05.11.25 | TruSpine Technolgs. - Change of Name | - | RNS | ||
| 15.10.25 | TruSpine Technolgs. - Subscription, Director/PDMR Dealing & RPT | - | RNS | ||
| 15.10.25 | Aquis Stock Exchange: Restoration to trading - TruSpine Technologies Plc | 236 | EQS Group (EN) | Aquis Stock Exchange
Aquis Stock Exchange: restoration to trading 15-Oct-2025 / 07:00 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen | |
| 14.10.25 | EARNINGS AND TRADING: Truspine loss widens; Abingdon's fund raise | 1 | Alliance News | ||
| 14.10.25 | TruSpine Technolgs. - Final Results | - | RNS | ||
| 01.10.25 | Aquis Stock Exchange: Suspension from trading - TruSpine Technologies Plc | 357 | EQS Group (EN) | Aquis Stock Exchange
Aquis Stock Exchange: suspension from trading 01-Oct-2025 / 09:17 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen | |
| 01.10.25 | TruSpine Technolgs. - Delay to the publication of accounts & Suspension | - | RNS | ||
| 22.08.25 | TruSpine Technologies firmiert um und nimmt Bitcoin in die Treasury-Strategie auf | - | Investing.com Deutsch | ||
| 22.08.25 | TruSpine Technologies to change name and adopt bitcoin treasury policy | 2 | Investing.com | ||
| 22.08.25 | TruSpine Technolgs. - Result of GM | - | RNS | ||
| 15.08.25 | TruSpine Technolgs. - Issue of Warrant | 3 | RNS | ||
| 04.08.25 | TruSpine to hold GM on bitcoin treasury policy, IP expansion plans | 2 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,510 | -0,04 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,500 | +1,26 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| FRESENIUS | 49,230 | -1,05 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| BETA BIONICS | 20,550 | -35,76 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,620 | -3,74 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,260 | -1,01 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| PROGYNY | 26,990 | -1,64 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| GERRESHEIMER | 27,400 | +0,37 % | Bechtle, Gerresheimer, HelloFresh, Kontron, Lanxess, TUI - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,755 | -0,93 % | Where Alignment Healthcare Stands With Analysts | ||
| CLEARPOINT NEURO | 14,950 | -2,35 % | ClearPoint Neuro schließt Zustimmungsvereinbarung zur Restrukturierung von IRRAS AB | ||
| GENEDX | 135,54 | -1,32 % | GeneDx partners with Komodo Health to create comprehensive rare disease dataset | ||
| PROCEPT BIOROBOTICS | 32,840 | -4,76 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| LUMEXA IMAGING | 16,840 | -5,02 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| INTELLIGENT BIO SOLUTIONS | 18,055 | +24,43 % | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | ||
| HEARTFLOW | 33,200 | -0,81 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen |